Actin disruption inhibits hypoxia inducible factor-1α expression via inactivity of Mdm2-mediated p70S6K

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 815-819

  Shin, Ik Jae ^a   Park, Bae Keun ^c   Ahn, Yong Tae ^e   Kim, Yongkuk ^d   An, Won G ^a,b  

^a Pusan National University   (South Korea)

^b School of Korean Medicine   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Kyungpook National University   (South Korea)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actin cytoskeleton; Hypoxia inducible factor 1 ; Jasplakinolide; Latrunculin B; Mammalian target of rapamycin; P70s6k; Petenotoxin 2

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; JASPAMIDE; LATRUNCULIN B; PECTENOTOXIN 2; PROTEIN MDM2; S6 KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; DEPOLYMERIZATION; DRUG MECHANISM; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN POLYMERIZATION;

MAMMALIA;

EID: 78049496424     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.325     Document Type: Article

References (25)

1. Schmidt A and Hall MN: Signaling to the actin cytoskeleton Annu Rev Cell Dev Biol 14: 305-338, 1998.
2. Allingham JS, Klenchin VA and Rayment I: Actin-targeting natural products: structures, properties and mechanisms of action. Cell Mol Life Sci 63: 2119-2134, 2006.
3. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999
4. Semenza GL: Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today 12: 853-859, 2007.
5. Hudson CC, Liu M, Chiang GG, et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22: 7004-7014, 2002.
6. Lasko P: Gene regulation at the RNA layer: RNA binding proteins in intercellular signaling networks. Sci STKE 179: re6, 2003.
7. Dutcher JP: Mammalian target of rapamycin inhibition. Clin Cancer Res 10: S6382-S6387, 2004
8. Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, MacRae EJ and Vousden KH: Phosphorylation of HDM2 by Akt. Oncogene 21: 1955-1962, 2002.
9. Fang J, Meng Q, Vogt PK, Zhang R and Jiang BH: A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability. J Cell Physiol 209: 261-265, 2006. (Pubitemid 44484615)
10. Bárdos JI, Chau NM and Ashcroft M: Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression. Mol Cell Biol 24: 2905-2914, 2004
11. Lau CK, Yang ZF, Lam CT, Tam KH, Poon RT and Fan ST: Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2). Biochem Biophys Res Commun 348: 1443-1448, 2006.
12. Jung JH, Sim CJ and Lee CO: Cytotoxic compunds from a two-sponge association. J Nat Prod 58: 1722-1726, 1995
13. Zhou J, Schmid T, Frank R and Brüne B: PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1 alpha from pVHL-independent degradation. J Biol Chem 279: 13506-13513, 2004 (Pubitemid 38468875)
14. Mabjeesh NJ, Post DE, Willard MT, Kaur B, van Meir EG, Simons JW and Zhong H: Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res 62: 2478-2482, 2002. (Pubitemid 34462721)
15. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL and van Obberghen E: Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277: 27975-27981, 2002.
16. Bubb MR, Senderowicz AM, Sausville EA, Duncan KL and Korn ED: Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 269: 14869-14871, 1994
17. Coue M, Brenner SL, Spector I and Korn ED: Inhibition of actin polymerization by latrunculin A. FEBS Lett 213: 316-318, 1987
18. Draisci R, Lucentini L, Giannetti L, Boria P and Poletti R: First report of pectenotoxin-2 (PTX-2) in algae (Dinophysis fortii) related to seafood poisoning in Europe. Toxicon 34 923-935, 1996. (Pubitemid 26274002)
19. Salnikow K, An WG, Melillo G, Blagosklonny MV and Costa M: Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20: 1819-1823, 1999
20. Wang GL and Semenza GL: Desferrioxamine induces erythropoietin gene expression and hypoxia inducible factor 1 DNA-binding activity: implicaitons for model of hypoxia signal transduction. Blood 82: 3610-3615, 1993.
21. Lang KJ, Kappel A and Goodall GJ: Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 13: 1792-1801, 2002. (Pubitemid 34522656)
22. Hay N and Sonenberg N: Upstream and downstream of mTOR Genes Dev 18: 1926-1945, 2004
23. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM: Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408, 1998.
24. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14 34-44, 2000. (Pubitemid 30051577)
25. Ryan KM, Phillips AC and Vousden KH: Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13: 332-337, 2001. (Pubitemid 32429498)